​

Funding Round

Series A - NexImmune

Series A - NexImmune

Investment Firm

Overview

NexImmune is a biopharmaceutical company developing novel immuno-therapeutics based on the proprietary artificial immune technology.

Announced Date

Jan 02, 2018

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

ArrowMark Partners

ArrowMark Partners

ArrowMark Partners is a debt and early_stage_venture and late_stage_venture and private_equity firm.

Participant Investors

1

Investor Name
Participant InvestorArrowMark Partners

Round Details and Background

NexImmune raised $23000000 on 2018-01-02 in Series A

NexImmune is a biopharmaceutical company developing novel immuno-therapeutics based on the proprietary artificial immune technology.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Feb 02, 2012
Venture Round - NexImmune
-1.0K
Jan 08, 2021
Convertible Note - NexImmune
1-50.0M
Feb 02, 2024
Post-IPO Equity - NexImmune
-3.7M
Jul 18, 2014
Venture Round - NexImmune
3-3.0M

Recent Activity

There is no recent news or activity for this profile.